BJL
ADPT icon

Brighton Jones LLC’s Adaptive Biotechnologies ADPT Stock Holding History

Brighton Jones LLC’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Sell
23,243
-260
-1% -$3.98K 0.01% 793
2026
Q1 		$326K Buy
+23,503
New +$374K 0.01% 890
2025
Q4 		– Sell
-23,301
Closed -$349K – 71
2025
Q3 		$349K Buy
23,301
+700
+3% +$8.53K 0.01% 755
2025
Q2 		$263K Buy
22,601
+283
+1% +$2.57K 0.01% 776
2025
Q1 		$166K Sell
22,318
-1,971
-8% -$15.1K 0.01% 665
2024
Q4 		$146K Hold
24,289
– – ﹤0.01% 655
2024
Q3 		$124K Sell
24,289
-1,000
-4% -$4.36K ﹤0.01% 557
2024
Q2 		$91.5K Sell
25,289
-1,200
-5% -$3.81K ﹤0.01% 611
2024
Q1 		$85K Buy
26,489
+604
+2% +$2.34K ﹤0.01% 612
2023
Q4 		$127K Sell
25,885
-14,895
-37% -$68K 0.01% 559
2023
Q3 		$222K Buy
40,780
+223
+0.5% +$1.48K 0.01% 476
2023
Q2 		$272K Buy
40,557
+543
+1% +$4.04K 0.01% 427
2023
Q1 		$353K Buy
40,014
+14,263
+55% +$126K 0.02% 349
2022
Q4 		$197K Sell
25,751
-8,107
-24% -$63.1K 0.01% 443
2022
Q3 		$241K Buy
33,858
+504
+2% +$4.75K 0.01% 376
2022
Q2 		$270K Buy
33,354
+352
+1% +$3.1K 0.02% 349
2022
Q1 		$458K Sell
33,002
-4,195
-11% -$66K 0.02% 293
2021
Q4 		$1.04M Sell
37,197
-7,972
-18% -$244K 0.05% 170
2021
Q3 		$1.53M Buy
45,169
+27
+0.1% +$977 0.08% 111
2021
Q2 		$1.84M Sell
45,142
-305
-0.7% -$11.9K 0.1% 98
2021
Q1 		$1.83M Sell
45,447
-1,485
-3% -$80.4K 0.11% 91
2020
Q4 		$2.77M Hold
46,932
– – 0.17% 56
2020
Q3 		$2.28M Buy
46,932
+395
+0.8% +$16.6K 0.16% 57
2020
Q2 		$2.25M Sell
46,537
-7,409
-14% -$270K 0.18% 51
2020
Q1 		$1.5M Buy
+53,946
New +$1.5M 0.16% 69

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brighton Jones LLC's ADPT Position: Q2 2026 in Review

Brighton Jones LLC reduced its Adaptive Biotechnologies (ADPT) stake by 1.1% in Q2 2026, selling an estimated $3.98K and leaving 23,243 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #793.

Brighton Jones LLC first reported a position in ADPT in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.77M in Q4 2020. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Brighton Jones LLC held 23,243 shares of Adaptive Biotechnologies worth $499K as of Q2 2026.
  • Brighton Jones LLC sold 260 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.98K.
  • Adaptive Biotechnologies made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #793 holding.
  • Brighton Jones LLC first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 25 quarters since.
  • Brighton Jones LLC's Adaptive Biotechnologies position peaked at $2.77M in Q4 2020.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.